Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/9/2017
SIETES contiene 92006 citas

 
 
 1 a 20 de 3192 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
2. Cita con resumen
Duan L, Ng A, Chen W, Spencer HT, Nguyen J, Shen AY-J, Lee M-S. ß-blocker exposure in pregnancy and risk of fetal cardiac anomalies. JAMA Intern Med 2017;177:885-7. [Ref.ID 101621]
3. Cita con resumen
Tsai W-C, Wu H-Y, Peng Y-S, Yang J-Y, Chen HY, Chiu Y-L, Hsu S-P, Ko M-J, Pai M-F, Tu Y-K, Hung K-Y, Chien K-L. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis. JAMA Intern Med 2017;177:792-9. [Ref.ID 101619]
4.Tiene citas relacionadas Cita con resumen
Curfman G. Risks of statin therapy in older adults. JAMA Intern Med 2017;177:966. [Ref.ID 101591]
5.Tiene citas relacionadas Cita con resumen
Han BH, Sutin D, Williamson JD, Davis BR, Piller LB, Pervin H, Pressel SL, Blaum CS, for the ALLHAT Collaborative Research Group. Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults. The ALLHAT-LLT randomized clinical trial. JAMA Intern Med 2017;177:955-65. [Ref.ID 101590]
6. Cita con resumen
Anónimo. Drugs for hypertension. The Medical Letter on Drug and Therapeutics Bulletin 2017;59:41-8. [Ref.ID 101527]
7. Cita con resumen
Chobanian AV. Hypertension in 2017- What is the right target?. JAMA 2017;317:579-80. [Ref.ID 101415]
8.Tiene citas relacionadas Cita con resumen
Puttnam R, Davis BR, Pressel SL, Whelton PK, Cushman WC, Louis GT, Margolis KL, Oparil S, Williamson J, Ghosh A, Einhorn PT, Barzilay JI, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Collaborative Research Group.. Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial. JAMA Intern Med 2017;177:67-76. [Ref.ID 101344]
10. Cita con resumen
Anónimo. Selexipag (Uptravi) for pulmonary arterial hypertension. Med Lett Drugs Ther 2016;58:21-3. [Ref.ID 100680]
11.Tiene citas relacionadas Cita con resumen
O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 2016;388:761-75. [Ref.ID 100609]
12.Tiene citas relacionadas Cita con resumen
Anónimo. Atrial fibrillation and stroke: unrecognised and undertreated. Lancet 2016;388:731. [Ref.ID 100608]
13. Cita con resumen
Whittle J. Blood pressure variability and cardiovascular risk. BMJ 2016;354:i4190. [Ref.ID 100604]
14. Cita con resumen
Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, McManus RJ. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ 2016;354:i4098. [Ref.ID 100603]
15. Cita con resumen
Mente A, O’Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Li W, Lu Y, Yi S, Rensheng L, Iqbal R, Mony P, Yusuf R, Yusoff K, Szuba A, Oguz A, Rosengren A, Bahonar A, Yusufali A, Schutte AE, Chifamba J, Mann JFE, Anand SS, Teo K, Yusuf S, for the PURE EPIDREAM and ONTARGET/TRANSCEND Investigators. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 2016;388:465-85. [Ref.ID 100513]
16. Cita con resumen
O'Brien E. Salt—too much or too little?. Lancet 2016;388:439-40. [Ref.ID 100512]
17.Tiene citas relacionadas Cita con resumen
Cunningham CJ. Research into “real world” older patients is needed. BMJ 2016;353:i3136. [Ref.ID 100379]
18.Tiene citas relacionadas Cita con resumen
Messerli FH, Bangalore S, Grossman E. Adverse effects and tolerability of ß blockers. BMJ 2016;353:i3142. [Ref.ID 100378]
19. Cita con resumen
Jackson JW. The cardiovascular safety of methylphenidate. BMJ 2016;353:i2874. [Ref.ID 100356]
Seleccionar todas
 
 1 a 20 de 3192 siguiente >>